U.S. National Institutes of Health
U.S. National Institutes of Health

IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
198661198661A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative VolunteersCompletedNo Results AvailableHIV Infections|HIV SeronegativityBiological: Salmonella typhi CVD 908-HIV-1 LAI gp 120 (VVG 203)|Biological: Aluminum hydroxide|Biological: MF59|Biological: rgp120/HIV-1MNhttps://ClinicalTrials.gov/show/NCT00000868
198662198662A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)CompletedNo Results AvailableAIDS Dementia Complex|HIV InfectionsDrug: Memantinehttps://ClinicalTrials.gov/show/NCT00000867
198663198663A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.CompletedNo Results AvailableHIV InfectionsBiological: MN rgp120/HIV-1|Biological: TBC-3B Vaccinehttps://ClinicalTrials.gov/show/NCT00000866
198664198664The Safety and Effects of 1592U89 Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Infants and ChildrenCompletedNo Results AvailableHIV InfectionsDrug: Abacavir sulfate|Drug: Lamivudine|Drug: Stavudine|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000865
198665198665A Study to Test the Safety, Tolerance, and Metabolism of Abacavir (1592U89, ABC) With Standard Zidovudine (ZDV) Therapy in Newborn Infants Born to HIV-1 Infected WomenCompletedNo Results AvailableHIV InfectionsDrug: Abacavir sulfate|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000864
198666198666A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected PatientsCompletedNo Results AvailablePneumonia, Pneumocystis Carinii|HIV InfectionsDrug: Sitamaquinehttps://ClinicalTrials.gov/show/NCT00000863
198667198667A Study of Zidovudine During Labor and Delivery in HIV-Infected Pregnant WomenCompletedNo Results AvailableHIV Infections|PregnancyDrug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000862
198668198668The Addition of Indinavir to Anti-HIV Treatment in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfatehttps://ClinicalTrials.gov/show/NCT00000861
198669198669The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected PatientsCompletedNo Results AvailableMycobacterium Avium-Intracellulare Infection|HIV Infectionshttps://ClinicalTrials.gov/show/NCT00000860
198670198670A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3CompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Ritonavir|Drug: Nelfinavir mesylatehttps://ClinicalTrials.gov/show/NCT00000859
198671198671Detection of Human Immunodeficiency Virus Type 1 (HIV-1) in Vaginocervical Secretions: Correlation With Clinical Status, Virologic and Immunologic Parameters, and the Presence of Other InfectionsCompletedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00000858
198672198672A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3CompletedNo Results AvailableHIV InfectionsDrug: Interleukin-12https://ClinicalTrials.gov/show/NCT00000857
198673198673A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.WithdrawnNo Results AvailableEncephalopathy|HIV Infections|RadiculitisDrug: Foscarnet sodium|Drug: Ganciclovirhttps://ClinicalTrials.gov/show/NCT00000856
198674198674A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women.CompletedNo Results AvailableHIV InfectionsDrug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000855
198675198675A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight LossCompletedNo Results AvailableHIV Infections|HIV Wasting SyndromeDrug: Nandrolone decanoatehttps://ClinicalTrials.gov/show/NCT00000854
198676198676A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of Low Dose MN rsgp120/HIV-1 (Genentech) in Combination With QS21 Adjuvant or Alum in Healthy AdultsCompletedNo Results AvailableHIV InfectionsBiological: rgp120/HIV-1MNhttps://ClinicalTrials.gov/show/NCT00000853
198677198677A Pilot Study of Allogeneic Lymphocyte Transfer in HIV InfectionCompletedNo Results AvailableHIV InfectionsProcedure: Allogeneic lymphocyte transferhttps://ClinicalTrials.gov/show/NCT00000852
198678198678Comparison of Stavudine Used Alone or in Combination With Didanosine in HIV-Infected ChildrenCompletedNo Results AvailableHIV InfectionsDrug: Stavudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000851
198679198679The Effectiveness of GM-CSF in HIV-Positive Patients Who Are Also Receiving Anti-HIV TherapyCompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Sargramostimhttps://ClinicalTrials.gov/show/NCT00000850
198680198680A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected ChildrenCompletedNo Results AvailableHIV InfectionsDrug: Aldesleukinhttps://ClinicalTrials.gov/show/NCT00000849
198681198681The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One YearCompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Saquinavirhttps://ClinicalTrials.gov/show/NCT00000848
198682198682A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult VolunteersCompletedNo Results AvailableHIV InfectionsBiological: ALVAC-HIV MN120TMG (vCP205)|Biological: ALVAC-RG Rabies Glycoprotein (vCP65)|Biological: rgp120/HIV-1 SF-2https://ClinicalTrials.gov/show/NCT00000847
198683198683A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.CompletedNo Results AvailableHIV InfectionsBiological: HIV-1 Peptide Vaccine, Microparticulate Monovalent|Biological: HIV-1 Peptide Immunogen, Multivalenthttps://ClinicalTrials.gov/show/NCT00000846
198684198684A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human SubjectsCompletedNo Results AvailableHIV InfectionsBiological: P3C541b Lipopeptidehttps://ClinicalTrials.gov/show/NCT00000845
198685198685A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and - CompletedNo Results AvailableHIV InfectionsDrug: Interferon alfa-n3|Drug: Interferon alfa-n1https://ClinicalTrials.gov/show/NCT00000844
198686198686The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected ChildrenCompletedNo Results AvailableHIV InfectionsDrug: Adefovir dipivoxilhttps://ClinicalTrials.gov/show/NCT00000843
198687198687A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory NeuropathyCompletedNo Results AvailableHIV Infections|Peripheral Nervous System DiseaseDrug: Nerve Growth Factor, Recombinant Humanhttps://ClinicalTrials.gov/show/NCT00000842
198688198688A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More MonthsCompletedNo Results AvailableHIV InfectionsDrug: Indinavir sulfate|Drug: Lamivudine|Drug: Stavudine|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00000841
198689198689A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNACompletedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00000840
198690198690A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant WomenCompletedNo Results AvailableHIV Infections|PregnancyDrug: Didanosinehttps://ClinicalTrials.gov/show/NCT00000839

* Görseller ve İçerik tekif hakkına sahip olabilir